title: Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C.
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tokumoto
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: N
authors.initials: N
authors.lastname: Ishikawa
authors.forename: T
authors.initials: T
authors.lastname: Simizu
authors.forename: T
authors.initials: T
authors.lastname: Oshima
authors.forename: S
authors.initials: S
authors.lastname: Noguchi
authors.forename: N
authors.initials: N
authors.lastname: Gouya
authors.forename: H
authors.initials: H
authors.lastname: Nakazawa
authors.forename: E
authors.initials: E
authors.lastname: Hashimoto
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: N
authors.initials: N
authors.lastname: Hayashi
authors.forename: H
authors.initials: H
authors.lastname: Toma
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D006435:Renal Dialysis
chemical_list: D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D012367:RNA, Viral